Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner
The filing is backed by Phase III data from the lidERA Breast Cancer study
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
This facility plays an important role in Granules’ global manufacturing and supply network
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
Subscribe To Our Newsletter & Stay Updated
